Literature DB >> 28476889

Structure of the human aminopeptidase XPNPEP3 and comparison of its in vitro activity with Icp55 orthologs: Insights into diverse cellular processes.

Rahul Singh1, Sahayog N Jamdar2, Venuka Durani Goyal1, Ashwani Kumar1, Biplab Ghosh1, Ravindra D Makde3.   

Abstract

The human aminopeptidase XPNPEP3 is associated with cystic kidney disease and TNF-TNFR2 cellular signaling. Its yeast and plant homolog Icp55 processes several imported mitochondrial matrix proteins leading to their stabilization. However, the molecular basis for the diverse roles of these enzymes in the cell is unknown. Here, we report the crystal structure of human XPNPEP3 with bound apstatin product at 1.65 Å resolution, and we compare its in vitro substrate specificity with those of fungal Icp55 enzymes. In contrast to the suggestions by earlier in vivo studies of mitochondrial processing, we found that these enzymes are genuine Xaa-Pro aminopeptidases, which hydrolyze peptides with proline at the second position (P1'). The mitochondrial processing activity involving cleavage of peptides lacking P1' proline was also detected in the purified enzymes. A wide proline pocket as well as molecular complementarity and capping at the S1 substrate site of XPNPEP3 provide the necessary structural features for processing the mitochondrial substrates. However, this activity was found to be significantly lower as compared with Xaa-Pro aminopeptidase activity. Because of similar activity profiles of Icp55 and XPNPEP3, we propose that XPNPEP3 plays the same mitochondrial role in humans as Icp55 does in yeast. Both Xaa-Pro aminopeptidase and mitochondrial processing activities of XPNPEP3 have implications toward mitochondrial fitness and cystic kidney disease. Furthermore, the presence of both these activities in Icp55 elucidates the unexplained processing of the mitochondrial cysteine desulfurase Nfs1 in yeast. The enzymatic and structural analyses reported here provide a valuable molecular framework for understanding the diverse cellular roles of XPNPEP3.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  X-ray crystallography; aminopeptidase; enzyme structure; metalloenzyme; tumor necrosis factor (TNF)

Mesh:

Substances:

Year:  2017        PMID: 28476889      PMCID: PMC5473211          DOI: 10.1074/jbc.M117.783357

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  The N-end rule pathway for regulated proteolysis: prokaryotic and eukaryotic strategies.

Authors:  Axel Mogk; Ronny Schmidt; Bernd Bukau
Journal:  Trends Cell Biol       Date:  2007-02-15       Impact factor: 20.808

2.  Aminopeptidase P from rat brain. Purification and action on bioactive peptides.

Authors:  H T Harbeck; R Mentlein
Journal:  Eur J Biochem       Date:  1991-06-01

3.  Dual targeting of Nfs1 and discovery of its novel processing enzyme, Icp55.

Authors:  Adi Naamati; Neta Regev-Rudzki; Shlomi Galperin; Roland Lill; Ophry Pines
Journal:  J Biol Chem       Date:  2009-08-31       Impact factor: 5.157

4.  Global analysis of the mitochondrial N-proteome identifies a processing peptidase critical for protein stability.

Authors:  F-Nora Vögtle; Stefanie Wortelkamp; René P Zahedi; Dorothea Becker; Claudia Leidhold; Kris Gevaert; Josef Kellermann; Wolfgang Voos; Albert Sickmann; Nikolaus Pfanner; Chris Meisinger
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

Review 5.  Mitochondrial quality control: a matter of life and death for neurons.

Authors:  Elena I Rugarli; Thomas Langer
Journal:  EMBO J       Date:  2012-02-21       Impact factor: 11.598

6.  Structure and mechanism of a proline-specific aminopeptidase from Escherichia coli.

Authors:  M C Wilce; C S Bond; N E Dixon; H C Freeman; J M Guss; P E Lilley; J A Wilce
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema.

Authors:  Amy L Cilia La Corte; Angela M Carter; Gillian I Rice; Qing Ling Duan; Guy A Rouleau; Albert Adam; Peter J Grant; Nigel M Hooper
Journal:  Hum Mutat       Date:  2011-09-12       Impact factor: 4.878

8.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard.

Authors:  Thomas C Terwilliger; Ralf W Grosse-Kunstleve; Pavel V Afonine; Nigel W Moriarty; Peter H Zwart; Li Wei Hung; Randy J Read; Paul D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2007-12-05
View more
  10 in total

1.  A Combined N-terminomics and Shotgun Proteomics Approach to Investigate the Responses of Human Cells to Rapamycin and Zinc at the Mitochondrial Level.

Authors:  Joanna Bons; Charlotte Macron; Catherine Aude-Garcia; Sebastian Alvaro Vaca-Jacome; Magali Rompais; Sarah Cianférani; Christine Carapito; Thierry Rabilloud
Journal:  Mol Cell Proteomics       Date:  2019-03-15       Impact factor: 5.911

2.  Extrapolation of Variant Phase in Mitochondrial Short-Chain Enoyl-CoA Hydratase (ECHS1) Deficiency.

Authors:  Colleen M Carlston; Sacha Ferdinandusse; Judith A Hobert; Rong Mao; Nicola Longo
Journal:  JIMD Rep       Date:  2018-06-20

3.  M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome.

Authors:  Sahana D Rao; Qifeng Chen; Qinghui Wang; Elizabeth L Orth-He; Michelle Saoi; Andrew R Griswold; Abir Bhattacharjee; Daniel P Ball; Hsin-Che Huang; Ashley J Chui; Dominic J Covelli; Shaochen You; Justin R Cross; Daniel A Bachovchin
Journal:  Nat Chem Biol       Date:  2022-02-14       Impact factor: 16.174

4.  Transcriptome-wide association study identifies new susceptibility genes and pathways for depression.

Authors:  Xiaoyan Li; Xi Su; Jiewei Liu; Huijuan Li; Ming Li; Wenqiang Li; Xiong-Jian Luo
Journal:  Transl Psychiatry       Date:  2021-05-21       Impact factor: 6.222

5.  P1' Residue-Oriented Virtual Screening for Potent and Selective Phosphinic (Dehydro) Dipeptide Inhibitors of Metallo-Aminopeptidases.

Authors:  Michał Talma; Artur Mucha
Journal:  Biomolecules       Date:  2020-04-24

Review 6.  Protein Processing in Plant Mitochondria Compared to Yeast and Mammals.

Authors:  Malgorzata Heidorn-Czarna; Agata Maziak; Hanna Janska
Journal:  Front Plant Sci       Date:  2022-02-02       Impact factor: 5.753

7.  Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development.

Authors:  Samuel Jacques; Almer M van der Sloot; Caroline C Huard; Jasmin Coulombe-Huntington; Sarah Tsao; Sylvain Tollis; Thierry Bertomeu; Elizabeth J Culp; Daniel Pallant; Michael A Cook; Eric Bonneil; Pierre Thibault; Gerard D Wright; Mike Tyers
Journal:  Genetics       Date:  2020-02-24       Impact factor: 4.562

Review 8.  Skeletal Phenotypes Due to Abnormalities in Mitochondrial Protein Homeostasis and Import.

Authors:  Tian Zhao; Caitlin Goedhart; Gerald Pfeffer; Steven C Greenway; Matthew Lines; Aneal Khan; A Micheil Innes; Timothy E Shutt
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

9.  Extra-mitochondrial mouse frataxin and its implications for mouse models of Friedreich's ataxia.

Authors:  Liwei Weng; Laurent Laboureur; Qingqing Wang; Lili Guo; Peining Xu; Leah Gottlieb; David R Lynch; Clementina Mesaros; Ian A Blair
Journal:  Sci Rep       Date:  2020-09-25       Impact factor: 4.379

Review 10.  Mitochondrial Protein Homeostasis and Cardiomyopathy.

Authors:  Emily Wachoski-Dark; Tian Zhao; Aneal Khan; Timothy E Shutt; Steven C Greenway
Journal:  Int J Mol Sci       Date:  2022-03-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.